Morgan Stanley Maintains Overweight on Vistra, Raises Price Target to $212

Benzinga Newsdesk www.benzinga.com Positive 81.3%

Neg 0% Neu 0% Pos 81.3%

Morgan Stanley analyst Stephen Byrd maintains Vistra (NYSE:VST) with a Overweight and raises the price target from $208 to $212.